Equity Overview
Price & Market Data
Price: $4.55
Daily Change: -$0.11 / 2.42%
Daily Range: $4.55 - $4.77
Market Cap: $204,210,576
Daily Volume: 16,837
Performance Metrics
1 Week: 3.88%
1 Month: -4.21%
3 Months: -1.52%
6 Months: -28.29%
1 Year: -56.25%
YTD: -1.09%
Company Details
Employees: 183
Sector: Health technology
Industry: Medical specialties
Country:
Details
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.